IVDr portal banner small
2016年12月 2日

Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs


Bruker Announces More Comprehensive and Efficient NMR Profiling Module for Detailed Lipoprotein Subclass Analysis in Cardiovascular Disease Research

2013年9月 4日

Bruker Announces Novel Approach for Inborn Errors of Metabolism (IEM) Screening by NMR

Clinical IEM-by-NMR Screening Study in Turkey Measures 65 Metabolites in Urine Simultaneously, Including 20 Endogeneous Metabolites and 45 Metabolites Associated with Inborn Errors of Metabolism


Bruker Announces AVANCE™-IVDr as a Standardized NMR Platform for Clinical Screening and In Vitro Diagnostics (IVD) Discovery and Validation

New AVANCE-IVDr System Offers High Performance and Throughput for the Development and Validation of Emerging High-Quality, Information-Rich and Cost-Effective IVD-by-NMR and Clinical Screening Assays